Berg T - Search Results

1

Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus(HCV)-Infektion.

Sarrazin C, Zimmermann T, Berg T, Hinrichsen H, Mauss S, Wedemeyer H, Zeuzem S; Deutsche Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS); Deutsche Gesellschaft für Pathologie e. V. (DGP) und Bundesverband Deutscher Pathologen (BDP); Deutsche Leberstiftung; Gesellschaft für Virologie e. V. (GfV); Gesellschaft für Pädiatrische Gastroenterologie und Ernährung (GPGE); Österreichische Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); Schweizerische Gesellschaft für Gastroenterologie (SGG); Deutsche Transplantationsgesellschaft e. V. (DTG); Deutsche Leberhilfe e. V.; Deutsche Gesellschaft für Infektiologie e. V. (DGI); Deutsche Gesellschaft für Suchtmedizin e. V. (DGS); Deutsche AIDS-Gesellschaft e. V. (DAIG); Deutsche Arbeitsgemeinschaft niedergelassener Ärzte für die Versorgung HIV-Infizierter (DAGNÄ); Robert Koch-Institut (RKI); Collaborators:. Sarrazin C, et al. Among authors: berg t. Z Gastroenterol. 2020 Nov;58(11):1110-1131. doi: 10.1055/a-1226-0241. Epub 2020 Nov 16. Z Gastroenterol. 2020. PMID: 33197953 German. No abstract available.

2

[Long-term follow-up of chronic hepatitis C after treatment with recombinant interferon alpha-2a].

Hopf U, Küther S, König V, Heuft H, Berg T, Bauditz J, Soltani K, Lobeck H, Huhn D. Hopf U, et al. Among authors: berg t. Z Gastroenterol. 1994 Aug;32(8):425-30. Z Gastroenterol. 1994. PMID: 7975783 Clinical Trial. German.

3

Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b undergoing combination therapy.

Sarrazin C, Berg T, Lee JH, Teuber G, Dietrich CF, Roth WK, Zeuzem S. Sarrazin C, et al. Among authors: berg t. J Hepatol. 1999 Jun;30(6):1004-13. doi: 10.1016/s0168-8278(99)80253-0. J Hepatol. 1999. PMID: 10406177

4

Interferon-antibodies and the breakthrough phenomenon during ribavirin/interferon-alpha combination therapy and interferon-alpha monotherapy of patients with chronic hepatitis C.

Hoffmann RM, Berg T, Teuber G, Prümmer O, Leifeld L, Jung MC, Spengler U, Zeuzem S, Hopf U, Pape GR. Hoffmann RM, et al. Among authors: berg t. Z Gastroenterol. 1999 Aug;37(8):715-23. Z Gastroenterol. 1999. PMID: 10494606 Clinical Trial.

5

Mutations in the protein kinase-binding domain of the NS5A protein in patients infected with hepatitis C virus type 1a are associated with treatment response.

Sarrazin C, Berg T, Lee JH, Rüster B, Kronenberger B, Roth WK, Zeuzem S. Sarrazin C, et al. Among authors: berg t. J Infect Dis. 2000 Feb;181(2):432-41. doi: 10.1086/315263. J Infect Dis. 2000. PMID: 10669323

6

Retreatment with interferon-alpha and ribavirin in primary interferon-alpha non-responders with chronic hepatitis C.

Teuber G, Berg T, Hoffmann RM, Leifeld L, Lafrenz M, Spengler U, Pape GR, Hopf U, Zeuzem S. Teuber G, et al. Among authors: berg t. Digestion. 2000;61(2):90-7. doi: 10.1159/000007740. Digestion. 2000. PMID: 10705172 Free article. Clinical Trial.

7

Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis C.

Zeuzem S, Teuber G, Naumann U, Berg T, Raedle J, Hartmann S, Hopf U. Zeuzem S, et al. Among authors: berg t. Hepatology. 2000 Oct;32(4 Pt 1):835-41. doi: 10.1053/jhep.2000.17740. Hepatology. 2000. PMID: 11003631 Free PMC article. Clinical Trial.

8

[Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].

Berg T, Kaul T, Naumann U, Wiedenmann B, Hopf U. Berg T, et al. Z Gastroenterol. 2000 Nov;38(11):881-6. doi: 10.1055/s-2000-10299. Z Gastroenterol. 2000. PMID: 11132533 Clinical Trial. German.

9

Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trial.

Berg T, Hoffmann RM, Teuber G, Leifeld L, Lafrenz M, Baumgarten R, Spengler U, Zeuzem S, Pape GR, Hopf U. Berg T, et al. Liver. 2000 Dec;20(6):427-36. doi: 10.1034/j.1600-0676.2000.020006427.x. Liver. 2000. PMID: 11169056 Clinical Trial.

10

Comparative sequence analysis of the core- and NS5-region of hepatitis C virus from tumor and adjacent non-tumor tissue.

Rüster B, Zeuzem S, Krump-Konvalinkova V, Berg T, Jonas S, Severin K, Roth WK. Rüster B, et al. Among authors: berg t. J Med Virol. 2001 Feb;63(2):128-34. J Med Virol. 2001. PMID: 11170049

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,213 results

Search Page